SA
Log In
XLRN
OverviewIntelligenceChart
+0.00%(+0.00)
Open
179.85
Prev Close
178.75
Day High
179.85
Day Low
177.20
Volume
7.9M
Avg Volume
1.3M
52W High
189.99
52W Low
111.75
Signal
Leaning Bullish1↑1!
Price
1→
Move→+0.00%Quiet session
Volume
1↑
Volume↑6.2× avgSurge — unusual activity
Technical
1→
RSI↑RSI 71Overbought
PRICE
Prev Close
178.75
Open
179.85
Day Range177.20 – 179.85
177.20
179.85
52W Range111.75 – 189.99
111.75
189.99
86% of range
VOLUME & SIZE
Avg Volume
1.3M
FUNDAMENTALS
P/E Ratio
0.0x
Value territory
EPS (TTM)
—
Div Yield
No dividend
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +6% YoY · 100% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 14.8 · FCF negative
Bullish
Key MetricsTTM
Market Cap$0.00
Revenue TTM$112.76M
Net Income TTM-$254.85M
Free Cash Flow-$266.56M
Gross Margin100.0%
Net Margin-179.4%
Operating Margin-180.8%
Return on Equity-25.5%
Return on Assets-17.8%
Debt / Equity0.03
Current Ratio14.85
EPS TTM$-2.92
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong3 concern
50/100
Liquidity
14.85Strong
Leverage
0.03Strong
Coverage
0.0xConcern
ROE
-25.5%Concern
ROIC
-19.0%Concern
Cash
$671MStrong
ANALYST COVERAGE23 analysts
BUY
▼ -15.5%downside to target
L $139.00
Med $151.00consensus
H $160.00
Buy
1878%
Hold
417%
Sell
14%
18 Buy (78%)4 Hold (17%)1 Sell (5%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
6/10
Technicals
●
RSI RangeRSI 71 — Overbought, caution
~
Fundamentals
●
Last EarningsMissed estimates
✗
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 14.85 — healthy liquidity
✓

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings Report · After CloseMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendGolden Cross · 50D leads 200D by 22.4%

+6.0% vs SMA 50 · +29.8% vs SMA 200

Momentum

RSI71.2
Overbought — pullback risk
MACD+2.57
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$190.0+6.3%
Current
$178.8
EMA 50
$166.2-7.0%
52W Low
$111.8-37.5%
EMA 200
$86.53-51.6%
52-Week RangeNear 52-week high
$111.886th %ile$190.0
Earnings & Analysts
Earnings HistoryXLRN
Last 8Q
-19.8%avg beat
Beat 1 of 8 quartersMissed 7↓ Estimates falling
-52%
Q1'20
-10%
Q2'20
+40%
Q3'20
-8%
Q4'20
-61%
Q1'21
-30%
Q2'21
-21%
Q3'21
-17%
Q4'21
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Kango SujayEVP, Chief Com…
$875K
Sep 27
SELL
Mclaughlin Kevin FSVP, CFO and T…
$3.0M
Sep 23
SELL
Mclaughlin Kevin FSVP, CFO and T…
$159K
Sep 23
SELL
Mclaughlin Kevin FSVP, CFO and T…
$861K
Sep 24
SELL
Kango SujayEVP, Chief Com…
$750K
Sep 21
SELL
Mccourt Thomas ADir
$252K
Apr 19
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
NEXT Financial Group, Inc
0▼
2
Grace Capital
0▼
3
SPHINX TRADING, LP
0▼
4
Omni Partners US LLC
30K▲
5
Marshall Wace North America L.P.
2K▲
6
KNOTT DAVID M
1K▲
7
Berman Capital Advisors, LLC
55▲
8
NorthCoast Asset Management LLC
0▼
News & Activity

XLRN News

20 articles · 4h ago

About

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Habib Dable
Website
www.acceleronpharma.com ↗

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance